Literature DB >> 20351040

Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls.

Dwight Dickinson1, Terry E Goldberg, James M Gold, Brita Elvevåg, Daniel R Weinberger.   

Abstract

INTRODUCTION: Separable, but positively correlated, factors emerge from analyses of cognitive test data in schizophrenia and control samples (eg, verbal memory and processing speed) and these factors guide data reduction. Additionally, data support a hierarchical model of cognitive performance, in which these correlations reflect the influence of a higher-order factor, referred to as "g." We tested these findings in large, carefully screened samples of people with schizophrenia (n = 496), their unaffected siblings (n = 504), and controls (n = 823). Furthermore, we tested the hypothesis that cognitive performance in schizophrenia is more generalized across domains than among siblings and controls.
METHOD: A combination of exploratory and confirmatory factor analyses (EFA and CFA) and multiple groups CFA (MCFA) was used.
RESULTS: EFA yielded factors for verbal memory, visual memory, processing speed, working memory span, nback performance, and card sorting. The solution was consistent across groups, in terms of the factor assignments of individual cognitive variables and the magnitude of loadings. Method variance may have contributed to the card sorting, visual memory, and nback factors. CFA indicated that the hierarchical model, incorporating a "g" factor, was a good fit for data from all groups. MCFA suggested that this hierarchical structure was fully invariant for controls and siblings. While the variable/factor loadings for the schizophrenia group also were invariant with comparison groups, factor/"g" loadings were higher in schizophrenia, as were correlations among factor-based composite scores.
CONCLUSIONS: Cognitive variables sort into domains consistently in schizophrenia, unaffected siblings, and controls. However, performance in schizophrenia is more generalized and less domain specific.

Entities:  

Mesh:

Year:  2010        PMID: 20351040      PMCID: PMC3196936          DOI: 10.1093/schbul/sbq018

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  20 in total

1.  Matching for education in studies of schizophrenia.

Authors:  S M Resnick
Journal:  Arch Gen Psychiatry       Date:  1992-03

2.  Longitudinal invariance of adult psychometric ability factor structures across 7 years.

Authors:  K Warner Schaie; Scott B Maitland; Sherry L Willis; Robert C Intrieri
Journal:  Psychol Aging       Date:  1998-03

3.  Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.

Authors:  M P Hobart; R Goldberg; J J Bartko; J M Gold
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

4.  Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes.

Authors:  S Kristian Hill; J Daniel Ragland; Ruben C Gur; Raquel E Gur
Journal:  J Clin Exp Neuropsychol       Date:  2002-09       Impact factor: 2.475

5.  Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

Authors:  T W Weickert; T E Goldberg; J M Gold; L B Bigelow; M F Egan; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2000-09

Review 6.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

7.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

8.  General and specific cognitive deficits in schizophrenia.

Authors:  Dwight Dickinson; Virginia N Iannone; Christopher M Wilk; James M Gold
Journal:  Biol Psychiatry       Date:  2004-04-15       Impact factor: 13.382

9.  General and specific cognitive deficits in schizophrenia: Goliath defeats David?

Authors:  Dwight Dickinson; J Daniel Ragland; James M Gold; Ruben C Gur
Journal:  Biol Psychiatry       Date:  2008-05-09       Impact factor: 13.382

10.  The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.

Authors:  Michael F Green; Stephen R Marder; Shirley M Glynn; Susan R McGurk; William C Wirshing; Donna A Wirshing; Robert P Liberman; Jim Mintz
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

View more
  39 in total

1.  A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes.

Authors:  Krista M Wisner; Brita Elvevåg; James M Gold; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2010-10-28       Impact factor: 4.939

2.  Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.

Authors:  Timothea Toulopoulou; Xiaowei Zhang; Stacey Cherny; Dwight Dickinson; Karen F Berman; Richard E Straub; Pak Sham; Daniel R Weinberger
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

3.  Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.

Authors:  Elsa Gilbert; Chantal Mérette; Valérie Jomphe; Claudia Emond; Nancie Rouleau; Roch-Hugo Bouchard; Marc-André Roy; Thomas Paccalet; Michel Maziade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-31       Impact factor: 5.270

4.  Intra-individual variability across neuropsychological tasks in schizophrenia: a comparison of patients, their siblings, and healthy controls.

Authors:  Veronica T Cole; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2011-04-05       Impact factor: 4.939

5.  Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.

Authors:  Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

6.  Sequential processing deficits in schizophrenia: relationship to neuropsychology and genetics.

Authors:  S Kristian Hill; Olivia Bjorkquist; Tarra Carrathers; Jarett E Roseberry; William C Hochberger; Jeffrey R Bishop
Journal:  Schizophr Res       Date:  2013-10-10       Impact factor: 4.939

7.  Memory systems in schizophrenia: Modularity is preserved but deficits are generalized.

Authors:  Kristen M Haut; Katherine H Karlsgodt; Robert M Bilder; Eliza Congdon; Nelson B Freimer; Edythe D London; Fred W Sabb; Joseph Ventura; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2015-08-20       Impact factor: 4.939

8.  Hippocampal Subregions Across the Psychosis Spectrum.

Authors:  Teresa Vargas; Derek J Dean; Kenneth Juston Osborne; Tina Gupta; Ivanka Ristanovic; Sekine Ozturk; Jessica Turner; Theo G M van Erp; Vijay Anand Mittal
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

9.  Development and testing of a web-based battery to remotely assess cognitive health in individuals with schizophrenia.

Authors:  Bruno Biagianti; Melissa Fisher; Benjamin Brandrett; Danielle Schlosser; Rachel Loewy; Mor Nahum; Sophia Vinogradov
Journal:  Schizophr Res       Date:  2019-02-04       Impact factor: 4.939

10.  Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).

Authors:  A McCleery; M F Green; G S Hellemann; L E Baade; J M Gold; R S E Keefe; R S Kern; R I Mesholam-Gately; L J Seidman; K L Subotnik; J Ventura; K H Nuechterlein
Journal:  Psychol Med       Date:  2015-04-28       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.